Role of Phosphodiesterase 4-Mediated Cyclic AMP Signaling in Pharmacotherapy for Substance Dependence

E-ISSN： 1873-4286|21|3|355-364

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.3, 2015-01, pp. : 355-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of Adolescent Substance Dependence

Child and Adolescent Psychopharmacology News, Vol. 9, Iss. 2, 2004-03 ,pp. : 1-6

Guilford Publications Inc

Access to resources Recommend Favorite

Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1688-1698

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of Dual Substance Abuse and Dependence

By Kenna George A.

CNS Drugs, Vol. 21, Iss. 3, 2007-01 ,pp. : 213-237

Adis International

Access to resources Recommend Favorite

Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B 4 biosynthesis in human polymorphonuclear leukocytes

By Denis D. Riendeau D.

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 343-350

Elsevier

Access to resources Recommend Favorite

PET Measurements of cAMP-Mediated Phosphodiesterase-4 with (R)-[11C]Rolipram

Current Radiopharmaceuticals, Vol. 4, Iss. 1, 2011-01 ,pp. : 44-58

Bentham Science Publishers

Access to resources Recommend Favorite